GALECTIN THERAPEUTICS (GALT) Covered Calls

GALECTIN THERAPEUTICS covered calls Galectin Therapeutics offers drug research & development to create new therapies for fibrotic disease & cancer. It has two compounds in development; one to be used in treatment of liver fibrosis & fatty liver disease & the other in cancer therapy.

You can sell covered calls on GALECTIN THERAPEUTICS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for GALT (prices last updated Fri 4:16 PM ET):

GALECTIN THERAPEUTICS (GALT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
4.94 -0.04 4.84 5.05 212K - 0.2B
Covered Calls For GALECTIN THERAPEUTICS (GALT)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 5 0.60 4.45 12.4% 156%
Jan 18 5 1.10 3.95 26.6% 106%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Galectin Therapeutics, Inc. operates as a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease and cancer. Its drug candidates are based on the method of targeting galectin proteins, which are key mediators of biologic and pathologic function and its focus is on diseases with serious, life-threatening consequences to patients and those where current treatment options are limited. The company was founded by James C. Czirr and Anatole A. Kltyosov on July 10, 2000 and is headquartered in Norcross, GA.